Medical isotopes and radiopharmaceuticals
3 European H2020 organizations list this as part of their work.
Most active in this area
- NARODOWE CENTRUM BADAN JADROWYCH
Poland's national nuclear research centre — reactor safety, particle physics, advanced materials, and medical isotope production across 32 H2020 projects.
“PRISMAP (medical isotope production by mass separation), SINFONIA (low-dose radiation risk in medicine), and NOMATEN's radiopharmaceuticals work stream.”
PL32 projects - INSTITUT MAX VON LAUE - PAUL LANGEVIN
World-leading neutron research facility in Grenoble providing beam access, instrumentation, and open data services across physics, materials, energy, and health.
“MEDICIS-PROMED, PRISMAP (medical isotope mass separation), and EU-QUALIFY (nuclear fuel for isotope-producing reactors) form a coherent medical applications thread.”
FR23 projects - EBG MEDAUSTRON GMBH
Austrian ion beam therapy centre combining clinical cancer treatment with particle accelerator research and medical isotope science.
“PRISMAP focuses on isotope mass separation for targeted molecular radiotherapy; MEDICIS-PROMED on radioisotope beam production for medicine.”
SMEAT5 projects